BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sherry AD, Passy AH, Abi Jaoude J, et al. (2025) Treatment group-specific inferences in Phase III Randomized Oncology Trials. Acta Oncologica (Stockholm, Sweden). 64: 470-474 |
| Sherry AD, Liu Y, Msaouel P, et al. (2025) Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials. Medrxiv : the Preprint Server For Health Sciences |
| Chang E, Sherry AD, Liermann J, et al. (2025) Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Cancer. 56: 47 |
| Miller AM, Passy AH, Sherry AD, et al. (2025) Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials. Jco Oncology Practice. OP2400735 |
| Sherry AD, Msaouel P, Lin TA, et al. (2024) Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials. Bmj Oncology. 3: e000322 |
| Kleber TJ, Sherry AD, Arifin AJ, et al. (2024) Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study. Journal of the National Cancer Institute |
| Sherry AD, Lin TA, McCaw ZR, et al. (2024) Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials. International Journal of Radiation Oncology, Biology, Physics |
| Sherry AD, Msaouel P, Kupferman GS, et al. (2024) Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in Oncology. Jco Precision Oncology. 8: e2400363 |
| Sherry AD, Msaouel P, Ludmir EB. (2024) A meta-epidemiological analysis of post-hoc comparisons and primary endpoint interpretability among randomized non-comparative trials in clinical medicine. Journal of Clinical Epidemiology. 111540 |
| Kouzy R, Ludmir EB, Hoffman KE, et al. (2024) In Reply to Akhtar et al. Practical Radiation Oncology. 14: 466-467 |